Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Pozycja w akcjach #27538
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Cena akcji
$0.0416118
Kapitalizacja rynkowa
$32.25M
Zmiana (1 dzień)
-1.67%
Zmiana (1 rok)
-59.58%
Kraj
AU
Handel Neurizon Therapeutics Limited (NUZ)

Kategoria

Historia ceny akcji dla Neurizon Therapeutics Limited (NUZ)
Najwyższa cena zamknięcia: $0.04 dnia 2026-08-01

Najniższa cena zamknięcia: $3.11 dnia 2001-10-01
Historia cen akcji firmy Neurizon Therapeutics Limited od 2001 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -8.62%
2025 -37.70%
2024 50.11%
2023 61.50%
2022 -33.17%
2021 -20.54%
2020 20.68%
2019 171.67%
2018 -30.35%
2017 4.90%
2016 -29.98%
2015 -55.93%
2014 -33.04%
2013 25.44%
2012 -54.31%
2011 -8.75%
2010 -46.71%
2009 152.12%
2008 -65.75%
2007 -55.38%
2006 -27.70%
2005 -34.70%
2004 20.98%
2003 69.43%
2002 -28.84%
2001 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$759.01 6.64%
CH